# Phase 1/2 stroke trials recruiting: 20 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 20 trials in phase 1/2 for stroke that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 1/2 stroke trials: 20 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-1-2/stroke

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 20
- Recruiting or not yet: 20
- Read on: November 19, 2026

## Trials

The 20 newest of 20, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 27, 2026 | NCT07896941 | Safety and Efficacy of CG-BM1 in Ischemic Stroke | GuangZhou Cellgenes Biotechnology Co., Ltd. | Phase 1/2 | Recruiting | Ischemic Stroke or High-risk TIA (ABCD² ≥ 4) | 87 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07896941) |
| August 25, 2026 | NCT07784231 | The Use of Photobiomodulation in the Treatment of Spasticity After Stroke. | University of Nove de Julho | Phase 1/2 | Recruiting | Stroke, Spasticity, Photobiomodulation, NIRS | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07784231) |
| June 9, 2026 | NCT07635758 | Human Placenta-derived 3D Mesenchymal Stem Cells(Guojianqingke) | Chinese PLA General Hospital | Phase 1/2 | Recruiting | Acute Ischemic Stroke | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07635758) |
| May 29, 2026 | NCT07613970 | Investigating Central Contributions to Fatigue Using Non-invasive Brain Stimulation | Vrije Universiteit Brussel | Phase 1/2 | Not yet recruiting | Stroke, Cerebrovascular Accident (CVA), Ischemia Stroke, Hemorrhage Stroke | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07613970) |
| February 10, 2026 | NCT07398612 | Safety and Efficacy of Human Adipose-Derived Stem Cell Exosomes in Acute Ischemic Stroke | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Phase 1/2 | Not yet recruiting | Acute Ischemic Stroke | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07398612) |
| January 28, 2026 | NCT07371624 | A Study of B2065 in Patients With Acute Ischemic Stroke | Tasly Pharmaceutical Group Co., Ltd | Phase 1/2 | Recruiting | Acute Ischemic Stroke | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07371624) |
| January 22, 2026 | NCT07359872 | Relaxin Therapy for Atrial Fibrillation | Sponsor not shown (see the record) | Phase 1/2 | Not yet recruiting | Atrial Fibrillation (AF), Arrhythmia, Oxidative Stress, Stroke, Major Cardiovascular Event, Heart Failure, Catheter... | 208 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07359872) |
| September 10, 2025 | NCT07166380 | RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric Infarction | Neurodawn Pharmaceutical Co., Ltd. | Phase 1/2 | Not yet recruiting | Transcranial Bone Marrow Injection, RK-4, Acute Large Hemispheric Infarction, Acute Ischemic Stroke | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07166380) |
| September 9, 2025 | NCT07163299 | Intra-arterial Selective Hypothermic Magnesium Sulfate Infusion in Combination With Endovascular Thrombectomy in Acute Ischemic Stroke | Capital Medical University | Phase 1/2 | Recruiting | Acute Ischemic Stroke | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07163299) |
| August 27, 2025 | NCT07143786 | Human Induced Neural Stem Cell-derived Exosomes for Treating Acute Ischemic Stroke | Xuanwu Hospital, Beijing | Phase 1/2 | Not yet recruiting | Ischemic Stroke, Acute | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07143786) |
| August 8, 2025 | NCT07113067 | Accelerated rTMS vs. Sham for Stroke Apathy | Medical University of South Carolina | Phase 1/2 | Recruiting | Apathy, Stroke, Stroke Sequelae, Stroke/Brain Attack, Stroke/ Cerebrovascular Accident (Ischemic or Hemorrhagic)... | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07113067) |
| May 31, 2025 | NCT06997939 | Autologous Bone Marrow Mesenchymal Stem Cell Therapy for Ischemic Stroke | Affiliated Hospital of Nantong University | Phase 1/2 | Not yet recruiting | Ischemic Stroke | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06997939) |
| April 4, 2025 | NCT06911385 | Augmenting Cerebral Blood Flow in Acute Ischemic Stroke | University of Alberta | Phase 1/2 | Not yet recruiting | Stroke | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06911385) |
| March 4, 2025 | NCT06857487 | Qingre Huatan Formula for the Prevention of Early Neurological Deterioration in Acute Ischemic Stroke | Dongzhimen Hospital, Beijing | Phase 1/2 | Recruiting | Acute Ischemic Stroke | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06857487) |
| May 8, 2024 | NCT06404268 | Facilitating Neuroplastic Changes of Acute Stroke Survivors | University of Maryland, Baltimore | Phase 1/2 | Recruiting | Stroke | 68 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06404268) |
| April 2, 2021 | NCT04830163 | Brain State-dependent PCMS in Chronic Stroke | University of Texas at Austin | Phase 1/2 | Not yet recruiting | Stroke | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04830163) |
| September 16, 2020 | NCT04550728 | Hybrid Robot+FES Stroke Rehabilitation | University of Maryland, Baltimore | Phase 1/2 | Recruiting | Stroke | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04550728) |
| November 20, 2017 | NCT03347786 | Verapamil for Neuroprotection in Stroke | Global Neurosciences Institute | Phase 1/2 | Recruiting | Ischemic Stroke | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03347786) |
| August 21, 2017 | NCT03255408 | Cerebral Blood Flow and Ventilatory Responses During Sleep in Normoxia and Intermittent Hypoxia | University of Calgary | Phase 1/2 | Recruiting | Obstructive Sleep Apnea of Adult, Hypoxia, Brain, Sleep Apnea, Sleep Disorder, Stroke, Blood Pressure, Endothelial... | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03255408) |
| December 23, 2015 | NCT02638701 | Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms | University of California, San Francisco | Phase 1/2 | Recruiting | Aneurysm, Stroke, Vasculitis, Tumor Necrosis Factor-alpha | 8 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02638701) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| University of Maryland, Baltimore | 2 |
| University of Calgary | 1 |
| Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 1 |
| Neurodawn Pharmaceutical Co., Ltd. | 1 |
| Xuanwu Hospital, Beijing | 1 |
| Chinese PLA General Hospital | 1 |
| GuangZhou Cellgenes Biotechnology Co., Ltd. | 1 |
| University of Alberta | 1 |
| Dongzhimen Hospital, Beijing | 1 |
| [Tasly Pharmaceutical Group Co., Ltd](https://specstream.ai/data/clinical-trials/company/tasly-pharmaceutical-group-co-ltd) | 1 |
| Capital Medical University | 1 |
| University of Nove de Julho | 1 |
| Global Neurosciences Institute | 1 |
| Medical University of South Carolina | 1 |
| Vrije Universiteit Brussel | 1 |
| University of Texas at Austin | 1 |
| Affiliated Hospital of Nantong University | 1 |
| University of California, San Francisco | 1 |

## By country

| Country | Trials |
| --- | --- |
| China | 7 |
| United States | 6 |
| Canada | 1 |
| Brazil | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [B2B water treatment companies in the United States](https://specstream.ai/data/businesses/b2b-water-treatment-companies/united-states)
- [Occupational safety services in the United States](https://specstream.ai/data/businesses/occupational-safety-services/united-states)
- [Ceiling and roofing repair and companies in the United States](https://specstream.ai/data/businesses/ceiling-and-roofing-repair-and-companies/united-states)
- [Prenatal and perinatal care clinics in the United States](https://specstream.ai/data/businesses/prenatal-and-perinatal-care-clinics/united-states)
- [Dermatology practices in the United States](https://specstream.ai/data/businesses/dermatology-practices/united-states)
- [Security system companies in the United States](https://specstream.ai/data/businesses/security-system-companies/united-states)
